NFKB1 and breast cancer: We did not observe any synergistic effects of ACE-I and EPA combination in BC cell proliferation and migration, possibly due to their competitive anti-inflammatory in vitro mechanisms of action via EGFR and/or NF-κB (Rel-A) signaling pathways [19,53].